supported by the grants from the National Natural Science Foundation of China (No.30572104,30772472)
Objective: Our previous study has showed that △DNMT3B is the predominant form of DNMT3B in non-small cell lung cancer (NSCLC). In this study, we aimed to explore the expression patterns of the △DNMT3B variants in...
This study was supported by grants from the National Natural Science Foundation of China (No. 30572104, 30772472), the Capital Medical Developing Foundation (No. 2005-2022), and the 985 Project (No. 985-2-013-39).
Background △DNMT3B (a new DNMT3B subfamily) expression is initiated through a novel promoter. We identified at least 7 transcription variants of △DNMT3B as a result of alternative pre-mRNA processing. The aim of t...